Who are Optina Diagnostics's investors?

Optina Diagnostics's investors include DigitalDx Ventures, Boehringer Ingelheim Venture Fund, Desjardins Capital, Hike Ventures, Zoic Capital.

Optina Diagnostics

10 known investors

Find your way into Optina Diagnostics

Optina develops a retinal imaging and AI platform for diagnosing and managing Age-Related Macular Degeneration in eye care specialists and patients. The platform combines hyperspectral imaging technology with AI clinical decision support to improve early detection and disease monitoring.

AI & Machine Learning Digital Health Medical Devices

Investors · 10

DigitalDx VenturesMenlo Park

Boehringer Ingelheim Venture FundreportedIngelheim am Rhein · $16.2M

Desjardins CapitalreportedMontreal

Hike VenturesreportedSan Francisco · $1M – $5M

Zoic CapitalreportedSeattle

Also in the syndicate · 5

Advisors FundBiomed PropulsionDigitalDxleadMedTeqMEDTEQ+

Funding

SEC filings, press & company announcements

Undisclosed amountSeries-AOct 2021
DigitalDx Ventures (lead), Advisors Fund, Biomed Propulsion, Boehringer Ingelheim Venture Fund, Desjardins Capital, Hike Ventures, MEDTEQ+
Source ↗
Undisclosed amountSeries AOct 2021 · 3 sources
DigitalDx (lead), DigitalDx Ventures (lead), Advisors Fund, Biomed Propulsion, Desjardins Capital, Hike Ventures, MedTeq, Zoic Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 2

by search overlap

Optain Health4 shared keywordsHealthcare technology company using robotic retinal imaging, AI and teleophthalmology to screen for eye and systemic disease.

Cognoptix3 shared keywordsCognoptix develops the Sapphire II system, a non-invasive laser eye scanning device paired with an eye ointment that binds to beta amyloid proteins in the lens of the eye to aid early detection and diagnosis of Alzheimer's disease. The company builds diagnostic devices and agents for clinical, commercial, and academic research use and works with pharma partners and academic institutes.

Companies competing with Optina Diagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Optina snags C$24.8m in DigitalDx-led Series A fundingventurecapitaljournal.com · Oct 2021

Optina raises $24 million to bolster AI-powered early Alzheimer detection device | BetaKitbetakit.com · Oct 2021

Optina Diagnostics Closes CA$24.8M Series A Funding Round - FinSMEsfinsmes.com · Oct 2021

Optina Diagnostics Closes an Oversubscribed Series-A Round of CA$24.8 millionprnewswire.com · Oct 2021

Supporting Optina Diagnostics with AI development and research funding - Centre de robotique et de vision industriellescrvi.ca · Apr 2021

CQDM is proud to be part of Optina Diagnostics' success - CQDMcqdm.org · Oct 2018

Frequently asked questions

What does Optina Diagnostics do?: Optina develops a retinal imaging and AI platform for diagnosing and managing Age-Related Macular Degeneration in eye care specialists and patients. The platform combines hyperspectral imaging technology with AI clinical decision support to improve early detection and disease monitoring.
Who are Optina Diagnostics's investors?: Optina Diagnostics's investors include DigitalDx Ventures, Boehringer Ingelheim Venture Fund, Desjardins Capital, Hike Ventures, Zoic Capital.